Dr.Reddy’s Labs is the top loser on the BSE, falling over 7% to Rs.2066.15.

The woes of the company seems to be getting only worse. Now it’s the German drug regulator – it concluded its audit of the manufacturing facility in Duvvuda, Vishakhapatanam. And it came up with zero critical but six major observations.

The Regulator has said that the products manufactured at the facility are not currently exported to the European Union (EU). It has said that the facility will receive EU-GMP certification from the Regulator up to November 2018 only when the Regulator approves the CAPA.

Dr.Reddy’s has said that it will be submitting a corrective and preventive action plan (CAPA) to the authorities.